Calliditas Therapeutics AB
STO:CALTX

Watchlist Manager
Calliditas Therapeutics AB Logo
Calliditas Therapeutics AB
STO:CALTX
Watchlist
Price: 208 SEK 0.87% Market Closed
Market Cap: 11.2B SEK
Have any thoughts about
Calliditas Therapeutics AB?
Write Note

Wall Street
Price Targets

CALTX Price Targets Summary
Calliditas Therapeutics AB

Wall Street analysts forecast CALTX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CALTX is 232.05 SEK with a low forecast of 178.77 SEK and a high forecast of 309.75 SEK.

Lowest
Price Target
178.77 SEK
14% Downside
Average
Price Target
232.05 SEK
12% Upside
Highest
Price Target
309.75 SEK
49% Upside
Calliditas Therapeutics AB Competitors:
Price Targets
4578
Otsuka Holdings Co Ltd
7% Downside
4516
Nippon Shinyaku Co Ltd
5% Downside
PBH
Prestige Consumer Healthcare Inc
12% Upside
603538
Ningbo Menovo Pharmaceutical Co Ltd
62% Upside
VIRP
Virbac SA
19% Upside
MMQ
Mind Medicine (MindMed) Inc
312% Upside
600521
Zhejiang Huahai Pharmaceutical Co Ltd
9% Upside
600535
Tasly Pharmaceutical Group Co Ltd
16% Upside

Revenue
Forecast

Revenue Estimate
Calliditas Therapeutics AB

The compound annual growth rate of Calliditas Therapeutics AB's revenue for the next 3 years is 57%.

N/A
Past Growth
57%
Estimated Growth
Estimates Accuracy
4%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Calliditas Therapeutics AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-17%
Average Miss

Net Income
Forecast

Net Income Estimate
Calliditas Therapeutics AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CALTX's stock price target?
Price Target
232.05 SEK

According to Wall Street analysts, the average 1-year price target for CALTX is 232.05 SEK with a low forecast of 178.77 SEK and a high forecast of 309.75 SEK.

What is Calliditas Therapeutics AB's Revenue forecast?
Projected CAGR
57%

The compound annual growth rate of Calliditas Therapeutics AB's revenue for the next 3 years is 57%.

Back to Top